drugset / Trial / NCT03883620
Safety Study of Dengushield in Healthy Adults
RandomizedParallel-groupTriple-blindTreatment
Summary
This Phase 1 study to evaluate the safety of a single dose of Dengushield (dengue monoclonal antibody) in healthy adults.
Timeline
- Start
- 2019-03-22
- Primary completion
- 2019-12-23
- Completion
- 2019-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dengushield | Unknown | 1 mg/kg | Intravenous |
| Subject | Dengushield | Unknown | 3 mg/kg | Intravenous |
| Subject | Dengushield | Unknown | 7 mg/kg | Intravenous |
| Subject | Dengushield | Unknown | 12 mg/kg | Intravenous |